PH16099A - Guanidinothiazole compounds,process for preparing them and medical composition containing them - Google Patents

Guanidinothiazole compounds,process for preparing them and medical composition containing them

Info

Publication number
PH16099A
PH16099A PH23689A PH23689A PH16099A PH 16099 A PH16099 A PH 16099A PH 23689 A PH23689 A PH 23689A PH 23689 A PH23689 A PH 23689A PH 16099 A PH16099 A PH 16099A
Authority
PH
Philippines
Prior art keywords
preparing
composition containing
medical composition
guanidinothiazole compounds
guanidinothiazole
Prior art date
Application number
PH23689A
Other languages
English (en)
Inventor
Hirata Yasufumi
Ishii Yoshio
Takeda Masaaki
Yanagisama Isao
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2574579A external-priority patent/JPS55118476A/ja
Priority claimed from JP7950879A external-priority patent/JPS565469A/ja
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of PH16099A publication Critical patent/PH16099A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
PH23689A 1979-03-06 1980-02-26 Guanidinothiazole compounds,process for preparing them and medical composition containing them PH16099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2574579A JPS55118476A (en) 1979-03-06 1979-03-06 Novel amidine derivative and its preparation
JP7950879A JPS565469A (en) 1979-06-23 1979-06-23 Novel amidine derivative and its preparation
KR1019800000932A KR830002478B1 (ko) 1979-03-06 1980-03-06 구아니디노 티아졸 화합물의 제조방법

Publications (1)

Publication Number Publication Date
PH16099A true PH16099A (en) 1983-06-24

Family

ID=27285138

Family Applications (1)

Application Number Title Priority Date Filing Date
PH23689A PH16099A (en) 1979-03-06 1980-02-26 Guanidinothiazole compounds,process for preparing them and medical composition containing them

Country Status (11)

Country Link
US (1) US4362736A (de)
CA (1) CA1145345A (de)
CH (1) CH644114A5 (de)
DE (1) DE3008056A1 (de)
ES (1) ES8103070A1 (de)
FR (1) FR2450827A1 (de)
GB (1) GB2052478B (de)
IT (1) IT1165509B (de)
NL (1) NL8001361A (de)
PH (1) PH16099A (de)
SE (1) SE447253B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196923A (en) * 1980-04-29 1983-12-16 Shionogi & Co 2-guanidino-4-(-acylaminoalkyl(thio)methyl)thiazoles and analogs
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
CA1209998A (en) * 1981-03-09 1986-08-19 David J. Gilman Amide derivatives as histamine h-2 receptor antagonists
IN158869B (de) * 1981-03-18 1987-02-07 Ici Plc
US4451463A (en) * 1981-03-24 1984-05-29 Imperial Chemical Industries Plc Alcohol derivatives
DE3267110D1 (de) * 1981-05-18 1985-12-05 Ici Plc Amidine derivatives
JPS5872571A (ja) * 1981-10-27 1983-04-30 Shionogi & Co Ltd 2−グアニジノ−4−〔2−(ホルムアミド)エチルチオメチル〕チアゾ−ルの製法
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
EP0103390A3 (de) * 1982-08-13 1986-02-26 Imperial Chemical Industries Plc Guanidin enthaltende Ester mit Histamin-H-2-Empfänger blockierender Wirkung
DE3238867A1 (de) * 1982-10-20 1984-04-26 Ludwig Heumann & Co GmbH, 8500 Nürnberg Heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS59104370A (ja) * 1982-12-03 1984-06-16 Kotobuki Seiyaku Kk チアゾ−ル誘導体及びその製造方法
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規2−グアニジノチアゾリン誘導体ならびにその製造法
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
GB8401751D0 (en) * 1984-01-24 1984-02-29 Ici Plc Guanidine derivatives
JPS6160673A (ja) * 1984-08-30 1986-03-28 Yamanouchi Pharmaceut Co Ltd グアニジノチアゾ−ル誘導体の製造法
CA1309557C (en) 1985-06-18 1992-10-27 Robert N. Young Leukotriene antagonists
DE3786030T2 (de) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
EP0284536A1 (de) * 1987-02-20 1988-09-28 Centro Marga Para La Investigacion S.A. Verfahren zur Herstellung von 3-(2-Guanidinothiazol-4-yl-methylthio)propionitril
EP0480716A1 (de) 1990-10-12 1992-04-15 Merck Frosst Canada Inc. Gesättigte Hydroxyalkylchinolinsäuren zur Verwendung als Leukotrien-Antagonisten
US5410054A (en) * 1993-07-20 1995-04-25 Merck Frosst Canada, Inc. Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
CA2628570A1 (en) 2005-11-09 2007-05-18 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
EP3018125B1 (de) 2013-07-03 2020-08-05 Shin Nippon Biomedical Laboratories, Ltd. Neuartige verbindung, nachweismittel für organischen kationentransporter 3 und hemmer der aktivität des organischen kationentransporters 3
WO2015155297A1 (en) 2014-04-11 2015-10-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (de) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmazeutische Kombinationen aus Rivaroxaban und Histamin-H2-Rezeptorantagonisten
WO2021183259A1 (en) * 2020-03-12 2021-09-16 Nanopharmaceutics, Inc. Famotidine and famotidine analogs for corona virus treatment
EP4196793A1 (de) 2020-08-11 2023-06-21 Université de Strasbourg Auf lebermakrophagen abzielende h2-blocker zur prävention und behandlung von lebererkrankungen und krebs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186965A (en) * 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
DE2817078C2 (de) * 1977-04-20 1995-06-14 Zeneca Ltd Guanidinderivate
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法

Also Published As

Publication number Publication date
CH644114A5 (de) 1984-07-13
FR2450827A1 (fr) 1980-10-03
ES489222A0 (es) 1981-02-16
FR2450827B1 (de) 1983-03-25
GB2052478B (en) 1983-04-07
DE3008056A1 (de) 1980-09-18
SE447253B (sv) 1986-11-03
IT8067346A0 (it) 1980-03-05
DE3008056C2 (de) 1988-07-21
SE8001691L (sv) 1980-09-07
US4362736A (en) 1982-12-07
NL8001361A (nl) 1980-09-09
ES8103070A1 (es) 1981-02-16
GB2052478A (en) 1981-01-28
IT1165509B (it) 1987-04-22
CA1145345A (en) 1983-04-26

Similar Documents

Publication Publication Date Title
PH16099A (en) Guanidinothiazole compounds,process for preparing them and medical composition containing them
DE3060129D1 (en) Tetrahydroisoquinoline compounds, process for preparing them and pharmaceutical compositions containing them
MY8500062A (en) 1,2,4-troazome deriovatives, process for preparing such compounds and pharmaceutical compositions containing them
DE3064173D1 (en) Novel 20-0-acylmaytansinoids, process for their preparation and pharmaceutical compositions containing them
DE2965763D1 (en) Tetrahydroisoquinoline compounds, process for preparing same and pharmaceutical compositions containing them
DE3167097D1 (en) Acylphosphinesulfide compounds, process for their preparation and their use
JPS52122632A (en) Medical composition and process for preparing same
GB2003471B (en) Heterocyclic compounds process for preparing them and medical compositions containing them
PH17189A (en) 2-acylaminomethyl-1,4-benzodiazepine and salts thereof,methods for preparing them and preparation containing these compounds
DE3071484D1 (en) Linear polychlorophosphazenes, process for their preparation and their use
DE3071581D1 (en) Substituted tetraazatricyclic compounds, process for their preparation, their use and medicines containing them
IL57416A0 (en) Nitro compounds,process for preparing them and compositions containing them
DE3067926D1 (en) Stabilising compounds, process for their preparation and compositions containing them
DE3065163D1 (en) New 4-fluoro-3-phenoxy-benzyl-ethers, process for their preparation and their use
HU179319B (en) Process for preparing 2-formyl-quinoxaline-1,4-dioxide-cyanoacetyl-hydrazones and compositions containing thereof
DE3167664D1 (en) Pyrazoloindazole derivatives, process for preparing the same, and pharmaceutical composition containing the same
JPS53127497A (en) Novel pyroloquinoxaline process for preparing same and medical composition
JPS53121789A (en) Penicilline process for preparing and medical composition containing same
DE3168442D1 (en) Tetrazolylcoumarin derivatives, process for preparing the same and composition containing the same
JPS53119803A (en) Monofluorophosphateamine process for preparing same and composition containing same
IL57415A (en) Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
DE2962567D1 (en) N-phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them
GB2073736B (en) Process for preparing pyridinyloxyphenoxy compounds and derivatives thereof
JPS5277081A (en) Pfnicillins process for preparing same and medical composition containing same
ZA807283B (en) Nicotinamide derivative,process for preparing the same and pharmaceutical composition containing the same